Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Acasti Pharma Inc. (ACST)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.3774-0.0183 (-4.62%)
At close: 04:00PM EST
0.4086 +0.03 (+8.27%)
After hours: 07:53PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3957
Open0.4000
Bid0.3750 x 1100
Ask0.4089 x 3000
Day's Range0.3700 - 0.4200
52 Week Range0.3700 - 1.7900
Volume168,632
Avg. Volume69,674
Market Cap16.956M
Beta (5Y Monthly)1.46
PE Ratio (TTM)13.98
EPS (TTM)0.0270
Earnings DateFeb 13, 2023 - Feb 17, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est5.00
  • GlobeNewswire

    Acasti Pharma Reports Second Quarter 2023 Operational Results

    Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced financial and operational results for the second quarter ended September 30, 2022. Recent Highlights The Company expects to receive guidance from the Food and Drug Administration (FD

  • GlobeNewswire

    Acasti Pharma to Present at Q4 Investor Summit

    LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced that Jan D’Alvise, President and CEO of Acasti Pharma will be presenting virtually at the Q4 Investor Summit. The Company will be conducting a webcasted presentation and participating in one-on-one meetings with investors. Event: Q4

  • GlobeNewswire

    Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

    Call to be held on Monday, November 14th at 1:00 PM Eastern TimeLAVAL, Quebec, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced that it will host a conference call at 1:00 PM Eastern Time on Monday, November 14, 2022, to discuss the Company’s corporate progress and other developments, as well as

Advertisement
Advertisement